Erin E Mulvihill
Overview
Explore the profile of Erin E Mulvihill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1857
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Basu L, Grieco-St-Pierre L, Ching M, Stead J, Hanson A, Palaniyandi J, et al.
Diabetes
. 2025 Jan;
PMID: 39808439
Cancer survivors have an increased risk of developing Type 2 diabetes compared to the general population. Patients treated with cisplatin, a common chemotherapeutic agent, are more likely to develop metabolic...
2.
Ewald J, Lu Y, Ellis C, Worton J, Kolic J, Sasaki S, et al.
Cell Metab
. 2024 Oct;
37(1):7-11.
PMID: 39357523
HumanIslets.com supports diabetes research by offering easy access to islet phenotyping data, analysis tools, and data download. It includes molecular omics, islet and cellular function assays, tissue processing metadata, and...
3.
Mullur N, Morissette A, Morrow N, Mulvihill E
J Endocrinol
. 2024 Aug;
263(1).
PMID: 39145614
Cardiovascular outcome trials (CVOTs) in people living with type 2 diabetes mellitus and obesity have confirmed the cardiovascular benefits of glucagon-like peptide 1 receptor agonists (GLP-1RAs), including reduced cardiovascular mortality,...
4.
Morissette A, Mulvihill E
Trends Endocrinol Metab
. 2024 Aug;
PMID: 39127552
Individuals with excessive adipose tissue and type 2 diabetes mellitus (T2DM) face a heightened risk of cardiovascular morbidity and mortality. Metabolic surgery is an effective therapy for people with severe...
5.
Chan J, Tabatabaei Dakhili S, Lorenzana-Carrillo M, Gopal K, Pulente S, Greenwell A, et al.
Cell Rep
. 2024 Aug;
43(8):114573.
PMID: 39093701
Growth differentiation factor 15 (GDF15) is a peptide with utility in obesity, as it decreases appetite and promotes weight loss. Because obesity increases the risk for type 2 diabetes (T2D)...
6.
Zierath J, van der Velden J, Javaheri A, Rosenzweig A, Muoio D, Mulvihill E, et al.
Cell
. 2024 Jul;
187(15):3880-3884.
PMID: 39059364
The future of healthcare for cardiovascular diseases holds immense promise, not only based in new discoveries in cardiac metabolism but also in translating them to solutions for critical challenges faced...
7.
Ewald J, Lu Y, Ellis C, Worton J, Kolic J, Sasaki S, et al.
bioRxiv
. 2024 Jul;
PMID: 38948734
Comprehensive molecular and cellular phenotyping of human islets can enable deep mechanistic insights for diabetes research. We established the Human Islet Data Analysis and Sharing (HI-DAS) consortium to advance goals...
8.
Morissette A, Mulvihill E
J Pharm Pharm Sci
. 2024 Jun;
27:13065.
PMID: 38903652
Excess adiposity can contribute to metabolic complications, such as type 2 diabetes mellitus (T2DM), which poses a significant global health burden. Traditionally viewed as a chronic and irreversible condition, T2DM...
9.
Smith T, Ghorbani P, LeBlond N, Nunes J, ODwyer C, Ambursley N, et al.
Atherosclerosis
. 2024 Jun;
397:117608.
PMID: 38880706
Background And Aims: Dysregulated cholesterol metabolism is a hallmark of atherosclerotic cardiovascular diseases, yet our understanding of how endogenous cholesterol synthesis affects atherosclerosis is not clear. The energy sensor AMP-activated...
10.
Garneau L, Mulvihill E, Smith S, Sparks L, Aguer C
Int J Mol Sci
. 2024 May;
25(9).
PMID: 38732106
Type 2 diabetes (T2D) is characterized by muscle metabolic dysfunction that exercise can minimize, but some patients do not respond to an exercise intervention. Myokine secretion is intrinsically altered in...